Pathology
 |
|
11 december 2019 17:00:46 |
| A novel CDK9 inhibitor increases the efficacy of venetoclax (ABT-199) in multiple models of hematologic malignancies (Leukemia) |
|
Tweet |
| 241 viewsCategory: Pathology |
 Familial myeloid malignancies with germline TET2 mutation (Leukemia)Do bedroom screens and the mealtime environment shape different trajectories of child overweight and obesity? Research using the Growing Up in Scotland study (International Journal of Obesity) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
